Indirect costs of depression and other mental and behavioural disorders for Australia from 2015 to 2030
Deborah Schofield(The University of Sydney), Megan Passey(Lismore Base Hospital), Simon Kelly(University of Canberra), Michelle Cunich(Macquarie University), Rupendra Shrestha(Macquarie University), Lennert Veerman(Griffith University), Robert Tanton(Deakin University)
Cited by 28
Related Papers
A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care—an international randomised controlled trial
|International Journal of Obesity|2012|2.1k
Diagnostic Impact and Cost-effectiveness of Whole-Exome Sequencing for Ambulant Children With Suspected Monogenic Conditions
|JAMA Pediatrics|2017|335
Prospective comparison of the cost-effectiveness of clinical whole-exome sequencing with that of usual care overwhelmingly supports early use and reimbursement
|Genetics in Medicine|2017|246
Whole-exome sequencing reanalysis at 12 months boosts diagnosis and is cost-effective when applied early in Mendelian disorders
|Genetics in Medicine|2018|200
Chronic disease and labour force participation among older Australians
|The Medical Journal of Australia|2008|189